Implementation of a universal rotavirus vaccination program: Comparison of two delivery systems

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Zelman, Mitchell ^a   Sanford, Carolyn ^a   Neatby, Anne ^a   Halperin, Beth A ^b,c,d   MacDougall, Donna ^b,e   Rowswell, Corinne ^a   Langley, Joanne M ^b,c,d   Halperin, Scott A ^b,c,d  

^a Department of Health and Wellness ^*  (Canada)

^b Canadian Center for Vaccinology Dalhousie University Halifax   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d IWK HEALTH CENTRE   (Canada)

^e ST FRANCIS XAVIER UNIVERSITY   (Canada)

Author keywords

Immunization delivery models; Immunization program; Program evaluation; Rotavirus infection; Rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE;

CANADA; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; INFANT; MALE; NURSE; ORGANIZATION AND MANAGEMENT; PHYSICIAN; PREVENTIVE HEALTH SERVICE; PROCEDURES; PROGRAM EVALUATION; ROTAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA; VACCINATION;

CANADA; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; NURSES, PUBLIC HEALTH; PHYSICIANS; PROGRAM EVALUATION; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 84907063941     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-908     Document Type: Article

References (27)

1. World Health Organization, Estimated rotavirus deaths for children under 5 years of age 2014 http://www.who.int/immunization/monitoring-surveillance/burden/estimates/rotavirus/en/index.html. Accessed 28 January 2014.
2. Global mortality associated with rotavirus disease among children in 2004. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI, J Infect Dis 2009 200 9 S15 10.1086/605025 19817620
3. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network, Lancet 2012 12 136 141 10.1016/S1473-3099(11)70253-5 22030330
4. Rotavirus overview. Bernstein DI, Ped Infect Dis J 2009 29 50 S53
5. Measuring the impact of rotavirus acute gastroenteritis (MIRAGE): a prospective community-based study. Senecal M, Brisson M, Lebel MH, Yaremko J, Wong R, Gallant LA, Can J Infect Dis Med Microbiol 2008 19 397 404 19436568
6. Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005-2007 IMPACT surveillance in Canadian hospitals. Le Saux N, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW, for members of the Canadian Immunization Monitoring Program, Active (IMPACT), Ped Infect Dis J 2010 29 879 892 10.1097/INF.0b013e3181e20c94
7. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. Clark HF, Offit PA, Ellis RW, Eiden JJ, Krah D, Shaw AR, Pichichero M, Treanor JJ, Borian FE, Bell LM, Plotkin SA, J Infect Dis 1996 174 73 S80 10.1093/infdis/174.Supplement-1.S73 8752294
8. Efficacy of live, attenuated human rotavirus vaccine 89-12 in infants. Bernstein DI, Sack DA, Rothstein E, Reisinger K, Ward RL, Lancet 1999 354 287 290 10.1016/S0140-6736(98)12106-2 10440305
9. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, Rotavirus Efficacy and Safety Trial (REST) Study Team, N Engl J Med 2006 354 23 33 10.1056/NEJMoa052664 16394299
10. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomized, double-blind controlled study. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A, Lancet 2007 370 1757 1763 10.1016/S0140-6736(07)61744-9 18037080
11. Rotavirus Vaccine. National Advisory Committee on Immunization, Canadian Immunization Guide 2014 http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-rot-eng.php. Accessed 30 January 2014
12. Canadian Immunization Committee, Recommendations for rotavirus immunization programs 2014 http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/14vol40/dr-rm40-02/dr-rm40-02-rota-eng.php. Accessed 30 January 2014
13. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation. Fisman DN, Chan CH, Lowcock E, Naus M, Lee V, Vaccine 2012 30 7601 7607 10.1016/j.vaccine.2012.10.034 23107595
14. Cost effectiveness of infant vaccination for rotavirus in Canada. Coyle D, Coyle K, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW, Le Saux N, Can J Infect Dis Med Microbiol 2012 23 71 77 23730312
15. Statistics Canada, Births and total fertility rate, by province and territory 2014 http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/hlth85a-eng.htm. Accessed 9 February 2014.
16. Statistics New Brunswick, Live Births by Age of Mother and Health Region of Residence, New Brunswick 2011 http://www.snb.ca/e/1000/1000-01/pdf-2011/T7-1B.pdf. Accessed 9 February 2014
17. An analytical framework for immunization programs in Canada. Erickson LJ, De Wals P, Farand L, Vaccine 2005 23 2470 2476 10.1016/j.vaccine.2004.10.029 15752833
18. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Parashar UD, Alexander JP, Glass RI, MMWR Recomm Rep 2006 55 RR12 1 13
19. National, State, and Local Area Vaccination Coverage Among Children Aged 19-35 Months-United States, 2012. Centers for Disease Control and Prevention, MMWR Morb Mortal Wkly Rep 2013 62 733 740 24025754
20. Recommendations of the Advisory Committee on Immunization Practice (ACIP). Quadrivalent human papillomavirus vaccine. Centers for Disease Control and Prevention, MMWR Recomm Rep 2007 56 RR02 1 24
21. Centers for Disease Control and Prevention, National Immunization Survey-Teen Data (Adolescents-Teens 13-17 years of age 2014 http://www.cdc.gov/vaccines/imz-managers/coverage/nis/teen/index.html. Accessed 1 March 2014.
22. Centers for Disease Control and Prevention, Vaccine-specific coverage among children 19-35 months, National Immunization Survey, 1994-2012 2014 http://www.dcd.gov/vaccines/imz-managers/coverage/nis/child/index.html. Accessed 1 March 2014
23. National immunization program in Finland. Rapola S, Int J Circumpolar Health 2007 66 382 389 18274204
24. First year experience of rotavirus immunization program in Finland. Leino T, Ollgren J, Salo H, Tiihonen P, Kilpi T, Vaccine 2012 31 176 182 10.1016/j.vaccine.2012.10.068 23122991
25. Population Health Assessment and Surveillance, School-based immunization coverage in Nova Scotia: 2008-09 to 2011-12 Nova Scotia: Department of Health and Wellness 2013 http://novascotia.ca/dhw/populationhealth/. Accessed 1 March 2014
26. Annual vaccine coverage statistics: England. Public Health England, NHS Immunisation Statistics England 2012-13 2014 http://www.hscic.gov.uk/catalogue/PUB11665/nhs-immu-stat-eng-2012-13-rep.pdf. Accessed 1 March 2014
27. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Amirthalingam G, Gupta S, Campbell H, Euro Surveill 2013 18 1 8 23449181